J&J falls after US judge rejects $10 bln baby powder settlement
Drug and devices maker Johnson & Johnson JNJ.N falls 2.7% to $161.41 premarket
U.S. bankruptcy judge rejects JNJ's $10 billion proposal to end tens of thousands of lawsuits alleging that its baby powder and other talc products cause ovarian cancer
This is the third time co's bankruptcy strategy has failed in court
J&J has been attempting to resolve the lawsuits through subsidiary company's bankruptcy, after two previous bankruptcy attempts failed in other courts
Leerink Partners says since the bankruptcy plan was dismissed, claimants can continue to proceed with individual trials against co
Stock gains 14.7% this year, as of last close
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
AMD Q1 Earnings: Data Center Revenue Surges 57% Driving Results Above Estimates, Shares Rise Over 16% After Hours

Micron Stock Forecast: Can the AI Memory Super-Cycle Drive MU to $3,000 by 2030?

Dell Stock Analysis: Is It Still Undervalued and the Best AI Infrastructure Play by 2026?

Meta Stock Price Forecast 2026-2030: Can META Hit $1,000?

Vanguard ETF Could Beat the S&P 500 Again in 2026 —— Why Investors Are Paying Attention

Tradingkey







